Biochemistry, Genetics and Molecular Biology
P53
100%
Cancer Model
100%
Cisplatin
57%
Mdm2
28%
Transactivation
21%
Wild Type
14%
DNA Damage
14%
Western Blot
7%
Cancer Cell
7%
P21
7%
Cytotoxicity
7%
Phosphotransferase
7%
Kinase
7%
Cyclin-Dependent Kinase
7%
Phosphoinositide 3-Kinase
7%
Protein P53
7%
Cross Resistance
7%
Neuroscience
P53
100%
Cancer Model
100%
Cisplatin
53%
Transactivation
20%
DNA Damage
13%
Cell Line
6%
Cytotoxicity
6%
Western Blot
6%
Kinase
6%
Chemotherapy
6%
Phosphoinositide 3-Kinase
6%
Wortmannin
6%
Cyclin-Dependent Kinase
6%
Pharmacology, Toxicology and Pharmaceutical Science
Protein P53
100%
Cancer Model
100%
Cisplatin
53%
Neoplasm
13%
Malignant Neoplasm
6%
Phosphotransferase
6%
Western Blot
6%
Cytotoxicity
6%
Antiinfective Agent
6%
Phosphatidylinositol 3 Kinase
6%
Cyclin Dependent Kinase Inhibitor
6%
Platinum Derivative
6%
Wortmannin
6%
Cross-Resistance
6%